Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
19,65 USD | +3,42% | +12,09% | +36,65% |
Attività
Numero di dipendenti: 142
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Troy Wilson
CEO | Chief Executive Officer | 55 | 22/08/14 |
Stephen Dale
CTO | Chief Tech/Sci/R&D Officer | 52 | 25/08/20 |
Kathleen Ford
COO | Chief Operating Officer | 77 | 09/08/19 |
Pete de Spain
IRC | Investor Relations Contact | - | 01/10/17 |
Thomas Doyle
AUD | Comptroller/Controller/Auditor | 53 | 01/06/21 |
Brian Powl
PRN | Corporate Officer/Principal | - | 14/08/23 |
Mollie Leoni
PRN | Corporate Officer/Principal | - | 01/02/20 |
Teresa Bair
LAW | General Counsel | 53 | 18/10/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Carol Schafer
BRD | Director/Board Member | 60 | 03/06/21 |
Faheem Hasnain
BRD | Director/Board Member | 65 | 27/04/15 |
Thomas Malley
BRD | Director/Board Member | 55 | 14/10/15 |
Mary Szela
BRD | Director/Board Member | 61 | 06/11/18 |
Troy Wilson
CEO | Chief Executive Officer | 55 | 22/08/14 |
Diane Parks
BRD | Director/Board Member | 72 | 14/10/19 |
Helen Collins
BRD | Director/Board Member | 61 | 29/07/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 76 180 620 | 73 510 311 ( 96,49 %) | 0 | 96,49 % |
Coordinate società
Kura Oncology, Inc.
12730 High Bluff Drive Suite 400
92130, San Diego
+858 500 8800
http://www.kuraoncology.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+36,65% | 1,5 Mrd | |
-2,31% | 103 Mrd | |
+0,56% | 95,28 Mrd | |
+1,69% | 22,15 Mrd | |
-17,37% | 21,02 Mrd | |
-9,30% | 18,15 Mrd | |
-41,01% | 16,74 Mrd | |
-14,85% | 16,05 Mrd | |
+3,21% | 13,68 Mrd | |
+33,54% | 12,17 Mrd |
- Borsa valori
- Azioni
- Azione KURA
- Società Kura Oncology, Inc.